Alibaba Group Holding Limited
NYSE:BABASpecialty Retail
-$1.28 today
- Market cap
- $209.89B
- Beta
- 0.46
- P/E (TTM)
- 17.2
- EPS (TTM)
- $5.25
- Dividend yield
- 0.98%
Volume 16.45M
Average 11.48M
BABA Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Alibaba Group Holding LimitedNYSE: BABA
Research & Development · Q1 FY2027 · quarter ended Jun 2026
Research & development growth accelerates
Q1 FY2027 research & development of CN¥22.47B rose 49.8% year over year, ahead of the +25.9% change in trailing-twelve-month research & development. Sequentially, it rose 18.5% from the prior quarter. Over 3 fiscal years it compounded at +5.4% a year.
Context
- Research & development amounted to 6.5% of revenue in FY2026, up 0.8 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +49.8% holds above the trailing-twelve-month pace of +25.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CNY · from the income statement
- Latest · FY2026
- 66.53B CNY
- Year-over-year change
- +16.4%
- 4-year CAGR
- +4.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 66.53B | +16.4% |
| FY2025 | 2025-03-31 | 57.15B | +9.4% |
| FY2024 | 2024-03-31 | 52.26B | -7.9% |
| FY2023 | 2023-03-31 | 56.74B | +2.3% |
| FY2022 | 2022-03-31 | 55.47B | — |
Research & Development vs competitors
How BABA compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +25.9% is the 3rd highest of 6, against a peer median of +20.9%.
- Research & development amounts to 7.1% of revenue for BABA, versus a peer median of 4.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $121.09B USD | +26.2% | +14.0% | 15.6% | |
| LTM Jun 2026 | CN¥74B CNY | +25.9% | +5.4% | 7.1% | |
| LTM Jun 2026 | CN¥18.31B CNY | +30.7% | +16.7% | 4.1% | |
| LTM Jun 2026 | $2.58B USD | +20.9% | +27.3% | 7.3% | |
| LTM Jun 2026 | CN¥1.8B CNY | -1.0% | +3.0% | 1.7% | |
| LTM Sep 2026 | $1.19B USD | +0.8% | -5.6% | 3.9% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding BABA) | — | +20.9% | +14.0% | 4.0% | |
Competitors are the stored peer set for BABA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 853.06B | 868.69B | 941.17B | 996.35B | 1.02T |
| Cost of Revenue | 539.45B | 549.7B | 586.32B | 598.29B | 616.14B |
| Gross Profit | 313.61B | 318.99B | 354.85B | 398.06B | 407.53B |
| Gross Margin | 36.8% | 36.7% | 37.7% | 40.0% | 39.8% |
| Research & Development | 55.47B | 56.74B | 52.26B | 57.15B | 66.53B |
| Selling, General & Admin | 151.72B | 145.68B | 157.13B | 188.26B | 278.11B |
| Operating Expenses | 243.97B | 218.64B | 241.5B | 257.16B | 357.38B |
| Depreciation & Amortization | 48.07B | 46.94B | 44.5B | 42.46B | 47.12B |
| EBITDA | 128.23B | 153.11B | 164.01B | 190.17B | 186.3B |
| EBITDA Margin | 15.0% | 17.6% | 17.4% | 19.1% | 18.2% |
| Operating Income | 69.64B | 100.35B | 113.35B | 140.91B | 50.15B |
| Operating Margin | 8.2% | 11.6% | 12.0% | 14.1% | 4.9% |
| Interest Income | 0 | 0 | 0 | 20.76B | 87.51B |
| Interest Expense | 20.61B | 16.99B | 17.91B | 9.6B | 9.79B |
| Other Income / Expenses | 4.26B | (19.23B) | (19.49B) | 20.52B | 82.02B |
| Income Before Tax | 73.89B | 81.12B | 93.86B | 161.42B | 132.17B |
| Pre-Tax Margin | 8.7% | 9.3% | 10.0% | 16.2% | 12.9% |
| Income Tax Expense | 26.82B | 15.55B | 22.53B | 35.45B | 30.05B |
| Net Income | 62.25B | 72.78B | 80.01B | 130.11B | 103.59B |
| Net Margin | 7.3% | 8.4% | 8.5% | 13.1% | 10.1% |
| EPS (Basic) | 22.96 | 27.68 | 31.60 | 55.12 | 45.60 |
| EPS (Diluted) | 22.72 | 27.44 | 31.36 | 53.60 | 44.00 |
| Weighted Avg Shares | 2.69B | 2.62B | 2.52B | 2.35B | 2.32B |
| Weighted Avg Shares (Diluted) | 2.72B | 2.64B | 2.54B | 2.41B | 2.4B |
Alibaba Group Holding Limited
NYSE:BABA
Intrinsic Alpha fair value
Locked
Current Price
$84.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.